AquaBounty Technologies (NASDAQ:AQB) Shares Up 3.1%

AquaBounty Technologies, Inc. (NASDAQ:AQBGet Free Report) rose 3.1% on Monday . The company traded as high as $1.67 and last traded at $1.66. Approximately 18,292 shares changed hands during trading, a decline of 24% from the average daily volume of 23,926 shares. The stock had previously closed at $1.61.

Analyst Ratings Changes

AQB has been the subject of several recent research reports. Oppenheimer reaffirmed a “market perform” rating on shares of AquaBounty Technologies in a research note on Tuesday, April 2nd. HC Wainwright reissued a “neutral” rating on shares of AquaBounty Technologies in a report on Thursday, May 16th.

Read Our Latest Research Report on AquaBounty Technologies

AquaBounty Technologies Stock Up 3.1 %

The company has a debt-to-equity ratio of 0.03, a quick ratio of 0.23 and a current ratio of 0.26. The stock’s 50 day simple moving average is $1.82 and its 200 day simple moving average is $2.11. The firm has a market cap of $6.41 million, a P/E ratio of -0.20 and a beta of 1.18.

AquaBounty Technologies (NASDAQ:AQBGet Free Report) last released its quarterly earnings results on Wednesday, May 15th. The company reported ($1.53) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($1.42) by ($0.11). The company had revenue of $0.48 million for the quarter, compared to analyst estimates of $0.50 million. AquaBounty Technologies had a negative net margin of 1,263.43% and a negative return on equity of 16.07%. Research analysts anticipate that AquaBounty Technologies, Inc. will post -4.86 EPS for the current year.

About AquaBounty Technologies

(Get Free Report)

AquaBounty Technologies, Inc, a biotechnology company, operates in the aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It also operates salmon farms using proprietary technology. In addition, the company offers AquAdvantage Salmon, a genetically engineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts.

Read More

Receive News & Ratings for AquaBounty Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AquaBounty Technologies and related companies with MarketBeat.com's FREE daily email newsletter.